Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first half of 2025 was 158 million yuan, representing a year-on-year decrease of 18.54% [1] - The net profit attributable to shareholders of the listed company was 9.3694 million yuan, down 71.78% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.4797 million yuan, a decrease of 88.44% year-on-year [1] - The basic earnings per share were 0.08 yuan [1]

Group 1 - The company reported a revenue of 158 million yuan for the first half of 2025, representing a year-on-year decline of 18.54% [1] - The net profit attributable to shareholders of the listed company was 9.37 million yuan, down 71.78% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.48 million yuan, a decrease of 88.44% year-on-year [1] - The basic earnings per share were 0.08 yuan [1]

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first half of 2025 was 158 million, representing a year-on-year decrease of 18.54% [1] - The net profit for the same period was 9.37 million, showing a substantial year-on-year decline of 71.78% [1] Dividend Policy - The company announced plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [1]

采纳科技股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：采纳科技股份有限公司 单位：万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与上 市公司的关 | 上市公司核算的 会计科目 | 2025 年期初占 用资金余额 | 2025 年半年度占 用累计发生金额 | 2025 年半年度 占用资金的利 | 2025 年半年度 偿还累计发生 | 2025 年 6 月末 占用资金余额 | 占用形成 原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 联关系 | | | （不含利息） | 息（如有） | 金额 | | | | | 控股股东、实际控制人及 | - | - | - | - | - | - | - | - | - | 非经营性 | | 其附属企业 | - | - | - | - | - | - | - | - | - | 非经营性 | | 小计 | - | - | - | - | - | - | - | - | - | - | | 前控股股东、实 ...

证券代码：301122 证券简称：采纳股份 公告编号：2025-080 采纳科技股份有限公司 第三届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 采纳科技股份有限公司（以下简称"公司"）第三届董事会第十六次会议通 知于 2025 年 8 月 15 日以邮件、电话等方式向各位董事发出，会议于 2025 年 8 月 26 日以现场会议形式，在江苏省江阴市祝塘镇环西路 23 号采纳医疗办公楼一 楼会议室召开。本次会议由公司董事长陆军先生主持，会议应出席董事 9 人，实 际出席董事 9 人，公司全体高级管理人员列席了会议。本次会议的召集、召开及 表决符合《中华人民共和国公司法》等有关法律、法规、规范性文件和《公司章 程》的规定。 二、董事会会议审议情况 1、审议通过《关于公司<2025 年半年度报告及其摘要>的议案》 经审议，该报告从主要会计数据和财务指标，报告期内公司所处的行业情况， 公司的主要业务分析等各方面反映了 2025 年上半年公司的经营情况。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 具体内 ...

采纳科技股份有限公司 2025 年半年度报告全文 采纳科技股份有限公司 2025 年半年度报告 2025 年 08 月 采纳科技股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法 律责任。 公司负责人陆军、主管会计工作负责人查凌云及会计机构负责人(会计主 管人员)查凌云声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中涉及的未来发展展望等前瞻性陈述不构成公司对投资者的实质 承诺，敬请广大投资者理性投资，注意风险。 公司在本半年度报告中详细阐述了未来可能发生的有关风险因素及对策， 详见"第三节管理层讨论与分析"之"十、公司面临的风险和应对措施"， 敬请投资者予以关注。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 1 | 第一节 | 重要提示、目录和释义 1 | | | --- | --- | --- | | 第二节 | 公司简介和主要财务指标 6 | | | 第三节 | 管理层讨论与分析 9 ...

证券代码：301122 证券简称：采纳股份 公告编号：2025-077 采纳科技股份有限公司 股东减持股份实施情况公告 | 股东名称 | 股份性质 | 本次变动前持有股份 | | 本次变动后持有股份 | | | --- | --- | --- | --- | --- | --- | | | | 股数 | 占总股本 | 股数 | 占总股本 | | | | (万股) | 比例(%) | (万股) | 比例(%) | | 中信保诚 | 合计持有股份 | 714.6348 | 5.8459 | 426.6453 | 3.4901 | | | 其中：无限售条件股份 | 714.6348 | 5.8459 | 426.6453 | 3.4901 | | | 有限售条件股份 | - | - | - | - | 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 采纳科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日在巨潮资 讯网（http://www.cninfo.com.cn）披露了《关于持股 5%以上股东股份减持计 划的预披露公告》公告编号：2025-023。持有公司股份 5%以上 ...

证券日报网讯 8月20日晚间，采纳股份公告称，公司全资子公司采纳医疗近日收到国家知识产权局颁发 的三项实用新型专利证书，分别为"一种耐压防逆流输液管路""压力显示注射器"和"固定计量注射器"。 上述专利为公司自主研发，其所涉及技术均与公司主营业务产品技术相关，专利权自授权公告之日起生 效。上述专利的取得和运用，不会对公司短期的经营业绩构成重大影响，但有利于公司进一步完善知识 产权保护体系，形成持续创新机制，保持技术的领先地位，提升公司的核心竞争力。 （文章来源：证券日报） ...

Core Viewpoint - The stock price of Canar Medical Co., Ltd. closed at 24.22 yuan on August 20, 2025, reflecting a decrease of 0.14 yuan or 0.57% from the previous trading day [1] Company Overview - Canar Medical operates in the medical device sector, focusing on the research, production, and sales of medical products, veterinary products, and laboratory consumables [1] - In the 2024 annual report, medical products accounted for 51.23% of the company's revenue, while veterinary products made up 39.03% [1] Recent Developments - On August 20, 2025, Canar Medical announced that its wholly-owned subsidiary, Jiangsu Canar Medical Technology Co., Ltd., received three utility model patent certificates from the National Intellectual Property Administration. The patents include "a pressure-resistant anti-backflow infusion pipeline," "a pressure display syringe," and "a fixed measurement syringe," all of which are related to the company's main business products [1] Financial Performance - On August 20, 2025, the main funds experienced a net outflow of 716,700 yuan, with a cumulative net outflow of 4,222,500 yuan over the past five days [1]

Group 1 - Weicai Technology achieved a net profit of 101 million yuan in the first half of 2025, a year-on-year increase of 831.03% [1] - The company reported an operating income of 634 million yuan, up 47.53% year-on-year, with a basic earnings per share of 0.68 yuan [1] - Weicai Technology specializes in wafer testing, chip finished product testing, and related integrated circuit testing services [1] Group 2 - Changhua Group received a project development notification from a domestic automotive company, with an expected total sales amount of approximately 190 million yuan over an 8-year lifecycle [2] - The project is set to begin mass production in the third quarter of 2026 [2] - Changhua Group focuses on the research, production, and sales of automotive metal components [2][3] Group 3 - Junhe Co. reported a net profit of 30.99 million yuan in the first half of 2025, a year-on-year decrease of 19.53% [3] - The company achieved an operating income of 578 million yuan, up 5.53% year-on-year, with a basic earnings per share of 0.08 yuan [3][4] - Junhe Co. specializes in the research, design, manufacturing, and sales of household water pumps and their accessories [4] Group 4 - Tonghua Jinma reported a net profit of 16.80 million yuan in the first half of 2025, a year-on-year increase of 34.77% [5] - The company achieved an operating income of 650 million yuan, a slight increase of 0.12% year-on-year, with a basic earnings per share of 0.0174 yuan [5] - Tonghua Jinma focuses on the research, production, and sales of pharmaceutical products [5][6] Group 5 - Xing Shuai reported a net profit of 122 million yuan in the first half of 2025, a year-on-year increase of 31.79% [8] - The company achieved an operating income of 1.132 billion yuan, up 8.59% year-on-year, with a basic earnings per share of 0.37 yuan [8] - Xing Shuai specializes in the research, production, and sales of various types of refrigeration compressor thermal protectors, starters, and temperature controllers [8] Group 6 - Ice Wheel Environment reported a net profit of 266 million yuan in the first half of 2025, a year-on-year decrease of 19.71% [9] - The company achieved an operating income of 3.118 billion yuan, down 6.92% year-on-year, with a basic earnings per share of 0.27 yuan [9] - Ice Wheel Environment focuses on the research, design, and sales of artificial environment control technology and energy comprehensive utilization technology [9][10] Group 7 - Jiangsu Huachen reported a net profit of 47.27 million yuan in the first half of 2025, a year-on-year increase of 18.37% [18] - The company achieved an operating income of 938 million yuan, up 40.46% year-on-year, with a basic earnings per share of 0.2901 yuan [18] - Jiangsu Huachen specializes in the research, production, and sales of energy-saving transformers and smart electrical equipment [18] Group 8 - Hanma Technology reported a net profit of 27.73 million yuan in the first half of 2025, reversing from a loss of 153 million yuan in the same period last year [18] - The company achieved an operating income of 2.847 billion yuan, a year-on-year increase of 50.03% [18] - Hanma Technology focuses on the production, research, and sales of heavy trucks, special vehicles, and automotive components [18] Group 9 - Tianyue Advanced announced the listing of its H-shares on the Hong Kong Stock Exchange, raising approximately 1.938 billion HKD [19] - The global offering consisted of 47.7457 million shares, with a price of 42.80 HKD per share [19] - Tianyue Advanced specializes in the research, production, and sales of silicon carbide semiconductor materials [19][20] Group 10 - Kesi Technology signed a sales framework contract worth up to 401 million yuan with Beijing Tianyuan Innovation Technology Co., Ltd. [21] - The contract is valid for two years and involves a comprehensive information integration service project [21] - Kesi Technology focuses on the research, development, manufacturing, and sales of electronic information equipment [21][22]